Editor's key points † Age effects in a cohort of young and old people on alterations of mid-latency auditory evoked potential (MLAEP) peak latencies in the awake state and under the influence of sevoflurane were studied. † MLAEP latencies increase at the influence of sevoflurane in a dose-dependent manner and in relation to age. † These results imply that MLAEP detection is a reasonable tool for monitoring hypnotic effects at all ages.
able to demonstrate that MLAEP in children aged 2-10 yr are sensitive to general anaesthesia using volatile anaesthetics 10 and can help to identify states of inadequate anaesthesia. 11 The objective of the present study was:
(i) to analyse the effects of increasing doses of sevoflurane on MLAEP latencies in infants, schoolchildren, and elderly people;
(ii) to verify changes of MLAEP latencies after the application of sufentanil in each age group during sevoflurane administration.
Methods
Thirty-two patients aged from 2 months to 89 yr [10 infants (2 months-3 yr); 12 schoolchildren (6-14 yr); 10 elderly (75 -89 yr)] undergoing elective surgery participated in this study between November 2006 and August 2007. Ethics committee approval was obtained before study start and the informed written consent was obtained from the parents or patients themselves. Only patients classified ASA I or II were enrolled into this study. Study exclusion took place if patients had a history of neurological or hearing disorders, surgery at the cranium, or the use or abuse of centrally acting substances. Also patients with a history of alcohol or drug abuse were not accepted. Standard clinical monitoring (ECG, pulse oximetry, oscillometric arterial pressure monitoring) was applied from the beginning of the patients' arrival at the operating theatre. After skin preparation with acetone, the Ag/AgCl adhesive electrodes (Neuroline 7200 00-S, Ambu/Medicotest, Denmark) for the measurement of AEPs were applied on A1, A2, Fp1, Fp2, Fpz, and Cz according to the international 10/20 system and adjustable headphones were placed at the ears. Interelectrode impedances were kept below 5 kV. All electrodes were connected to a special preamplifier (POD, Siemens Medical, Erlangen, Germany) wired to feed four recording channels (A1/Fp1, A2/Fp2, A1/Cz, and A2/Cz with Fpz as the common ground). The signals were amplified and digitized (sensitivity 0.017 mV, sampling rate 4 kHz) within the preamplifier and transmitted to the recording system via broadband glass fibre cables. Data were stored on the measuring computer unit. In an offline analysis with a special program (NaMo v. 8.0, Toennies/Viasys, Hoechberg, Germany), 1000 successive EEG epochs of 100 ms duration after each stimulus were extracted. To obtain one single high-quality AEP for each channel, 1000 EEG epochs were recorded during 108 s of anaesthesia. In some cases, single EEG epochs of the 1000 were rejected due to fact that the amplitudes were above the cutting point. This occurred, for example, during the application of electric devices (e.g. heating mattress, electrocauter). This is the reason why only an approximate time of one AEP collection-in our study 108 s-can be given. Every AEP signal was inspected visually and the channel with the best recordings was selected for each patient. Furthermore, visual analyses with quality control were revised by two investigators (M.F. and G.F.) aware of the order of recordings but blinded to the patient's age and further clinical data such as sevoflurane concentration. The quality of every signal was classified as excellent, acceptable, or insufficient for interpretation. AEP signals evaluated as distorted or insufficient for interpretation were excluded from further analysis. The nomenclature of Picton and colleagues 1 for AEP was applied; the negative and positive peaks of the MLAEP were identified and marked as Na, Pa, Nb, and P1. In addition, peak V of the BAEP was identified and marked as a control of adequate AEP detection (data not shown). A first AEP recording was started during the premedicated state while the patients were awake and calm with eyes open.
Anaesthetic regime in infants and schoolchildren
Except two infants, everyone received 0.3 mg kg 21 midazolam orally or rectally 30 min before general anaesthesia (Table 1) . In all 22 children, anaesthesia was induced via a face mask using 8 vol% sevoflurane and 100% oxygen with a high fresh gas flow; thereafter, an i.v. cannula was placed.
Anaesthetic regime in elderly people
The elderly were premedicated with 0.06 mg kg 21 
Statistical analysis
To test differences in the MLAEP between the age groups and also between defined comparable 'consciousness' states, one-way analysis of variance (ANOVA) was planned, followed by closed testing pairwise comparisons. On behalf of the experience of our previous studies, group size was calculated to be 10 participants in the three age groups each (desired power 0.8, minimum detectable difference in means 15 for peak latency Pa, expected standard deviation of residuals 10). 10 Closed testing the three pairwise comparisons needs no adjustments.
To search for statistical differences in the MLAEP in the age groups at different MAC levels, one-way repeatedmeasures (RM) ANOVA was applied in extension.
Deviation from normal distribution of sample data was detected by the Kolmogorov-Smirnov test. Hence, the Kruskal-Wallis test and the Wilcoxon-Mann-Whitney test were applied in addition for verification, and further analysis preferred non-parametric methods.
A non-parametric Wilcoxon's signed-rank test was performed to look for differences in MLAEP values between anaesthesia with and without sufentanil application.
A linear regression analysis and Spearman's correlation analysis were performed for all MLAEP latencies with respect to different sevoflurane concentrations and MAC levels. Regression curves, R 2 values, and correlation coefficients are presented for linear modelling, and P-values for statistical tests.
To search for significant differences in the MLAEP in the age groups at different MAC levels, one-way RM ANOVA followed by pairwise comparisons using closed testing was applied. This method was also used for comparison of MLAEP values between the age groups and defined comparable 'consciousness' states.
A non-parametric Wilcoxon's signed-rank test was performed to look for significant differences in MLAEP values between anaesthesia with and without sufentanil application.
The significance level was 0.05, not adjusted for multiple testing in explorative analyses. Results are expressed as mean (SD), Sigmastat w (Jandel Corp., San Rafael, CA, USA).
Results
The patient characteristics and also the anaesthetic information are presented in detail in Table 1 . All MLAEP data from the 32 patients were enclosed for further analysis. At the awake state, 19 of the 32 individual AEP were rated excellent, 13 were classified as acceptable. The data quality intraoperatively remained overall stable for the selected channel: an average of 25.3 individual AEP were classified excellent whereas 6.7 AEP met the criteria acceptable. For the awake state, every MLAEP peak was detected earlier with increasing age. Under anaesthesia with sevoflurane, this finding was reversed and all peak latencies showed a later appearance in time ( Fig. 1 and Table 2 ).
With increasing MAC levels of sevoflurane, the peak latency of the MLAEP was significantly increased. This finding was not specific to one single age class but was demonstrated in all age groups (Table 3 ). In the data analyses, the two most suitable peaks of the MLAEP in describing the diversity to MAC levels were Peak Pa and Nb (Fig. 2) . These results of the increase in latency were also seen with significant differences when the volume percentages (vol%) of sevoflurane were analysed (Fig. 3) . Owing to the study's technical limitations, all latencies were displayed within a time window up to 100 ms. Thus, at the highest sevoflurane concentration peak P1 and in some cases also latency Nb crossed this upper limit.
To compare different age groups, comparable states have to be found. In this study, these criteria were achieved at the awake phase, the influence of 1.3 vol% and 2.3 vol% sevoflurane. During the awake phase, no statistical significant differences could be seen between the age groups. Nevertheless, MLAEP peak latencies appeared earlier with increasing age (Table 4) . In contrast to this are the states of sevoflurane application. Compared with the infants, an increase in the peak latency of Nb and P1 could already be seen at 1.3 vol% sevoflurane in schoolchildren and in the elderly. This difference remained stable at the influence of 2.3 vol% sevoflurane compared with the infants concerning the peak Nb. P1 was already at the upper measuring limit and so no differences could be further detected (Table 4 ). The significant differences between age groups could be confirmed by the non-parametric tests.
The application of sufentanil had no influence on MLAEP latencies in all different patient groups at the concentration of 1 MAC sevoflurane, as assessed in six infants, six schoolchildren, and four elderly people met the criteria (Table 5) .
Discussion
In continuation of our previous work, 10 we now recorded MLAEP not only in children but also in infants from the youngest age of 2 months during general anaesthesia. Changes of MLAEP latencies under general anaesthesia with volatile anaesthetics are a well-described phenomenon 5 6 8 13 in adults. The dose-dependent alteration of latencies in adult patients was previously reported by Schwender and colleagues. 6 For this reason, we did not investigate the group of adults in our study separately. Very few reports on MLAEP recording in children are available and almost no data can be reviewed for MLAEP in infants so far. 9 11 14 15 Taking this together, we investigated age effects in a cohort of young and old people on alterations of MLAEP peak latencies in the awake state and under the influence of sevoflurane. There was a clear Table 2 .
Effects of increasing sevoflurane MAC levels on MLAEP BJA reduction in peak latencies with increasing age during the premedicated, contactable awake phase. A reduction in those peak latencies was also previously reported in children and young adults, whereas an assimilation at the age of 10 yr was described. 15 16 Owing to a dynamic development of the relevant central nervous structures 17 and the few cases in our study, we did not look for such a cut-off age. Under the influence of sevoflurane, peak latencies appeared, in contrast to the awake state, later in the elderly. This matches perfectly with findings on end-tidal sevoflurane concentrations and age-dependency in correlation with the neurophysiological bispectral index (BIS) monitoring. Cortinez and colleagues 18 nicely demonstrated, with the help of a pharmacodynamic model, the dynamic relationship between end-tidal sevoflurane concentrations and BIS values. As we did treat age as a continuous variable but did not monitor the group of adults, the presented age-dependent regression analyses have some limitations. For this reason, we also investigated single age groups. Taking into account that the age groups are quite small in sample size, the results have to be regarded carefully, as some comparisons could be underpowered, even though we did not adjust the significance level for multiple comparisons. Nevertheless, we found that in all groups, latencies significantly increased with higher minimal alveolar concentrations of sevoflurane. As the MAC is an age-dependent and corrected value, 19 volume percentages of sevoflurane were additionally recorded during AEP detection. 12 20 The reason why MAC levels of sevoflurane were chosen was to evaluate the MAC system in correspondence with changes in MLAEP latencies. As the data from Table 3 and Figure 2 nicely show, there is a clear correlation between MAC levels and MLAEP increase in each age group. However, the age-correction, when using the MAC system, overlaps the actual effect of sevoflurane concentrations in different age groups and is in this way a limiting factor. For this reason, specific comparable states including the premedicated awake phase and continuous levels of 1.3 vol% and 2.3 vol% end-tidal sevoflurane were used to compare age effects on MLAEP peaks. Elderly people need less sevoflurane to achieve similar MLAEP latencies when compared with infants. This is consistent with the findings when age was treated as a continuous parameter (Table 2) . It is a well-known phenomenon that volatile anaesthetics have an agedependency in onset and maintenance of expiratory levels.
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These findings give a new perspective to MLAEP alteration under general anaesthesia in different age groups. As previously reported by the investigators and also by others, 10 22 a significant decrease in MLAEP latencies can be found in the awake child up to an age of 12 yr due to effects of maturation processes of the auditory pathway. 17 The results here show that age-related MLAEP changes primarily exist under general anaesthesia with sevoflurane. Furthermore, we investigated the influence of sufentanil on MLAEP latencies. Several authors investigated the effect of opioids on MLAEP, 23 -25 showing only slight changes in the specific MLAEP latencies. This is in good accordance with the presented results here for the patients at 1 MAC sevoflurane where the latencies remain stable after the application of sufentanil. As this study was performed in a clinical set-up, some limitations of this examination have to be addressed. Besides two patients, everyone received midazolam as premedication. In the group of the infants, the highest doses of midazolam per kilogram body weight were given. Accordingly, the group of elderly received the lowest amount. By reviewing the literature, it was shown that the single application of benzodiazepine did not markedly alter MLAEP 27 where little changes occurred in MLAEP latency for midazolam when the patients remained awake. This could be in our study one confounder, although all patients were awake and contactable. Another limitation is that anaesthesia was induced in the elderly using a single shot of low-dose etomidate. Taking into account that the elderly often react with a delayed response to centrally acting substances, 28 this could have influenced our results, as this is a different anaesthetic induction technique. Etomidate is known to increase MLAEP latencies when applied as a continuous infusion. 29 To minimize this possibility, an additional 10 min were waited before the dose-related AEP measurements were performed. For this reason, we assume that at the time of Table 3 . 
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